These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19. Yasamineh S; Kalajahi HG; Yasamineh P; Gholizadeh O; Youshanlouei HR; Matloub SK; Mozafari M; Jokar E; Yazdani Y; Dadashpour M Stem Cell Res Ther; 2022 Jun; 13(1):257. PubMed ID: 35715852 [TBL] [Abstract][Full Text] [Related]
9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494 [TBL] [Abstract][Full Text] [Related]
10. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges]. Wang J; Zou W; Liu J Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563 [TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery. Couto PS; Al-Arawe N; Filgueiras IS; Fonseca DLM; Hinterseher I; Catar RA; Chinnadurai R; Bersenev A; Cabral-Marques O; Moll G; Verter F Front Immunol; 2023; 14():1200180. PubMed ID: 37415976 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use. Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Corsico AG Cells; 2020 Apr; 9(4):. PubMed ID: 32283815 [TBL] [Abstract][Full Text] [Related]
13. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R; Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not. Akkoc T Adv Exp Med Biol; 2020; 1298():167-176. PubMed ID: 32648245 [TBL] [Abstract][Full Text] [Related]
15. Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems. Kodama T; Obinata H; Mori H; Murakami W; Suyama Y; Sasaki H; Kouzaki Y; Kawano S; Kawana A; Mimura S J Infect Chemother; 2021 Feb; 27(2):336-341. PubMed ID: 33402303 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol. Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS Syst Rev; 2021 Sep; 10(1):249. PubMed ID: 34526123 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of SARS-CoV-2 pneumonia diagnosed in a primary care practice in Madrid (Spain). Guisado-Clavero M; Herrero Gil A; Pérez Álvarez M; Castelo Jurado M; Herrera Marinas A; Aguilar Ruiz V; Gefaell Iarrondo I; Menéndez Orenga M; Ares-Blanco S BMC Fam Pract; 2021 Apr; 22(1):83. PubMed ID: 33926382 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome. Harrell CR; Jovicic BP; Djonov V; Volarevic V Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics. Yadav P; Vats R; Bano A; Bhardwaj R Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279 [TBL] [Abstract][Full Text] [Related]
20. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave. Carrasco I; Muñoz-Chapuli M; Vigil-Vázquez S; Aguilera-Alonso D; Hernández C; Sánchez-Sánchez C; Oliver C; Riaza M; Pareja M; Sanz O; Pérez-Seoane B; López J; Márquez E; Domínguez-Rodríguez S; Hernanz-Lobo A; De León-Luis JA; Sánchez-Luna M; Navarro ML BMC Pregnancy Childbirth; 2021 Apr; 21(1):326. PubMed ID: 33902483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]